✦ LIBER ✦

Dacarbazine and tamoxifen in patients with advanced melanoma: An effective therapy option?

✍ Scribed by Rass, K.; Seiter, S.; Uhl, K.; Petzoldt, D.; Tilgen, W.

Book ID: 123434459
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 389 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(97)86080-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential administration of dacarbazine

Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma—an effective combination with unexpected toxicity

✍ Aamdal, S.; Bohman, T.; Gerard, B.; D'Incalci, M. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 434 KB

Phase II study of second-line therapy wi

Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine

✍ Propper, D J; Braybrooke, J P; Levitt, N C; O’Byrne, K; Christodoulos, K; Han, C 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB

Does polychemotherapy with dacarbazine,

Does polychemotherapy with dacarbazine, vindesine and clsplatin represent a useful therapeutic alternative in patients with advanced melanoma?

✍ Seiler, S.; Uhl, K.; Rass, K.; Kratofiel, M.; Petzoldt, D.; Tilgen, W 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 259 KB

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

Combinatorial Therapy Targeting GRM1 And

Combinatorial Therapy Targeting GRM1 And MEK As A Therapeutic Option In Patients With Melanoma

✍ S. Shaikh; S. Rosenberg; K.T. Merrigan; Y. Wen; J.S. Goydos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Combined treatment with pegylated interf

Combined treatment with pegylated interferon–α-2a and dacarbazine in patients with advanced metastatic melanoma : A phase 2 study

✍ Axel Hauschild; Reinhard Dummer; Selma Ugurel; Katharina C. Kaehler; Friederike 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB